查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1532412

细胞冷冻保存市场：按产品类型、按应用、按最终用户、按地区

Cell Cryopreservation Market, By Product Type, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 192 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球细胞冷冻保存市场规模将达101亿美元，预计2031年将达431.1亿美元，2024年至2031年复合年增长率为23%。

报告范围 报告详情
基准年 2023年 2024年市场规模 101亿美元
实际资料 2019-2023 预测期 2024年至2031年
预测 2024-2031 年复合年增长率： 23.00% 2031年价值预测 431.1亿美元
图. 2024年各地区细胞冷冻保存市场占有率（%）
细胞冷冻保存市场-IMG1

细胞冷冻保存使用液态氮在极低的温度（通常低于-80°C）下冷却并保存细胞。细胞可以保存很久而不影响细胞活力。癌症和遗传疾病的增加、再生医学研究、干细胞库、生育治疗和组织工程投资的增加等因素可能会推动研究机构和医院对细胞冷冻保存过程的需求。冷冻保存设备和解决方案的技术进步也将支持市场成长。然而，与冷冻保存程序和设备相关的高成本可能会阻碍预测期内的市场成长。

市场动态：

全球细胞冷冻保存市场成长的主要驱动力是慢性和危及生命的疾病盛行率的上升。癌症和遗传疾病的全球流行正在推动对严重依赖冷冻细胞的研究活动、细胞疗法和临床试验的需求。根据世界癌症研究基金会的数据，2020 年全球将报告约 1,800 万新癌症病例。此外，公共和私人对再生医学、干细胞研究和医学生物技术创新的投资增加也支持了冷冻保存流程的采用。然而，与冷冻保存设备、液态氮和整体程序相关的高成本可能会阻碍市场成长。此外，缺乏熟练的专业人员以及耗时的冷冻过程中的技术挑战也可能阻碍市场成长。机器人冷冻保存技术和设备的持续市场开拓可能会提供利润丰厚的市场成长机会。

本研究的主要特点

  • 本报告详细分析了全球细胞冷冻保存市场，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
  • 它揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球细胞冷冻保存市场的主要企业。
  • 该报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球细胞冷冻保存市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球细胞冷冻保存市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管场景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球细胞冷冻保存市场 - 冠状病毒（COVID-19）大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球细胞冷冻保存市场，依产品类型，2019-2031

  • 防冻剂
  • 甘油
  • 二甲基亚砜(DMSO)
  • 其他的
  • 装置
  • 培养箱
  • 液态氮供应罐
  • 冷冻库
  • 其他的

第六章全球细胞冷冻保存市场，依应用分类，2019-2031

  • 干细胞
  • 卵子和胚胎细胞
  • 精子细胞
  • 肝细胞
  • 其他的

第 7 章 全球细胞冷冻保存市场，依最终使用者划分，2019-2031 年

  • 生物製药和製药公司
  • 研究所
  • 生物样本库
  • 试管婴儿诊所
  • 其他的

第八章全球细胞冷冻保存市场，按地区，2019-2031，（十亿美元）

  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东

第9章 竞争格局

  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GE Healthcare
    • Lonza Group Ltd.
    • STEMCELL Technologies Inc.
    • BioLife Solutions, Inc.
    • Cryolife, Inc.
    • Organ Recovery Systems Inc.
    • Custom Biogenic Systems
    • Sartorius AG
    • Takara Bio Inc.
    • Chart Industries, Inc.
    • Biocision, LLC
    • Cardinal Health, Inc.
    • Helmer Scientific

第10章分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会图

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI1698

Global cell cryopreservation market is estimated to be valued at USD 10.10 Bn in 2024 and is expected to reach USD 43.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 23% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 10.10 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 23.00% 2031 Value Projection: US$ 43.11 Bn
Figure. Cell Cryopreservation Market Share (%), By Region 2024
Cell Cryopreservation Market - IMG1

Cell cryopreservation involves preserving cells by cooling them to extremely low temperatures, usually -80°C or below using liquid nitrogen. It helps to preserve cells for a very long period of time without affecting their viability. Factors such as rising prevalence of cancers and genetic disorders, increasing investments in regenerative medicine research, stem cell banking, fertility preservation and tissue engineering can boost demand for cell cryopreservation processes across research institutes and hospitals. Technological advancements in cryopreservation equipment and solutions can also drive the market growth. However, high costs associated with cryopreservation procedures and equipment can hamper the market growth during the forecast period.

Market Dynamics:

Global cell cryopreservation market growth is mainly driven by rising incidence of chronic and life-threatening diseases. Growing prevalence of cancers and genetic disorders globally boosts demand for research activities, cell therapies and clinical trials which heavily rely on cryopreserved cells. According to the World Cancer Research Fund, approximately 18 million new cancer cases were reported globally in 2020. Furthermore, increasing investments by both public and private players in regenerative medicine, stem cell research and medical biotech innovations have also boosted the uptake of cryopreservation processes. However, high costs associated with cryopreservation equipment, liquid nitrogen and overall procedures can hamper the market growth. Lack of skilled professionals and technical challenges during slow freezing processes can also hamper the market growth. Ongoing developments in robotic cryostorage technologies and equipment can offer lucrative market growth opportunities.

Key Features of the Study:

  • This report provides in-depth analysis of the global cell cryopreservation market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cell cryopreservation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, Nippon Genetics, Miltenyi Biotec, Mediatech, Inc., Genzyme Corporation, BioLifeSolutions, Inc., VWR International, LLC, and BiolifeSolutions, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global cell cryopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell cryopreservation market

Detailed Segmentation-

  • By Product Type
    • Cryoprotectant Agents
    • Glycerol
    • Dimethyl Sulfoxide (DMSO)
    • Others
    • Equipment
    • Incubators
    • Liquid Nitrogen Supply Tanks
    • Freezers
    • Others
  • By Application
    • Stem Cells
    • Oocytes and Embryotic cells
    • Sperm Cells
    • Hepatocytes
    • Others
  • By End User
    • Biopharmaceutical & Pharmaceutical Companies
    • Research Institutes
    • Biobanks
    • IVF clinics
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GE Healthcare
    • Lonza Group Ltd.
    • STEMCELL Technologies Inc.
    • BioLife Solutions, Inc.
    • Cryolife, Inc.
    • Organ Recovery Systems Inc.
    • Custom Biogenic Systems
    • Sartorius AG
    • Takara Bio Inc.
    • Chart Industries, Inc.
    • Biocision, LLC
    • Cardinal Health, Inc.
    • Helmer Scientific

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Cell Cryopreservation Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Cell Cryopreservation Market, By Product Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Cryoprotectant Agents
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Glycerol
  • Dimethyl Sulfoxide (DMSO)
  • Others
  • Equipment
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Incubators
  • Liquid Nitrogen Supply Tanks
  • Freezers
  • Others

6. Global Cell Cryopreservation Market, By Application, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Stem Cells
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Oocytes and Embryotic cells
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Sperm Cells
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Hepatocytes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Cell Cryopreservation Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Biopharmaceutical & Pharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Biobanks
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • IVF clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Cell Cryopreservation Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck KGaA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GE Healthcare
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Lonza Group Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • STEMCELL Technologies Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • BioLife Solutions, Inc.
    • Cryolife, Inc.
    • Organ Recovery Systems Inc.
    • Custom Biogenic Systems
    • Sartorius AG
    • Takara Bio Inc.
    • Chart Industries, Inc.
    • Biocision, LLC
    • Cardinal Health, Inc.
    • Helmer Scientific

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact